Rank | Gene Set | Z-score |
---|---|---|
1 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.22018565 |
2 | synaptic vesicle exocytosis (GO:0016079) | 5.88093555 |
3 | vocalization behavior (GO:0071625) | 5.50456697 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.38800523 |
5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.33768089 |
6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.31605460 |
7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.28644757 |
8 | nucleobase catabolic process (GO:0046113) | 5.24163721 |
9 | glutamate secretion (GO:0014047) | 5.22911539 |
10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.20819059 |
11 | protein-cofactor linkage (GO:0018065) | 5.17963939 |
12 | protein localization to synapse (GO:0035418) | 5.17549651 |
13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.10852724 |
14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.07983138 |
15 | neuron cell-cell adhesion (GO:0007158) | 4.85312357 |
16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.83388743 |
17 | glutamate receptor signaling pathway (GO:0007215) | 4.74690529 |
18 | neuron-neuron synaptic transmission (GO:0007270) | 4.56722852 |
19 | synaptic transmission, glutamatergic (GO:0035249) | 4.51168601 |
20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.46898794 |
21 | locomotory exploration behavior (GO:0035641) | 4.45887431 |
22 | regulation of synaptic vesicle transport (GO:1902803) | 4.39231952 |
23 | presynaptic membrane assembly (GO:0097105) | 4.27429580 |
24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.23810653 |
25 | synaptic vesicle maturation (GO:0016188) | 4.22799611 |
26 | neuronal action potential propagation (GO:0019227) | 4.22750328 |
27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.22479574 |
28 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.19329051 |
29 | establishment of mitochondrion localization (GO:0051654) | 4.16918777 |
30 | cell migration in hindbrain (GO:0021535) | 4.14951573 |
31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.13128814 |
32 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.10291392 |
33 | long-term synaptic potentiation (GO:0060291) | 4.08916491 |
34 | exploration behavior (GO:0035640) | 4.04960285 |
35 | neuronal ion channel clustering (GO:0045161) | 4.02856793 |
36 | glycosphingolipid biosynthetic process (GO:0006688) | 3.98917213 |
37 | positive regulation of mitochondrial fission (GO:0090141) | 3.98341919 |
38 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.96343458 |
39 | synapse assembly (GO:0007416) | 3.94216631 |
40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.93475515 |
41 | presynaptic membrane organization (GO:0097090) | 3.93398230 |
42 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.91812740 |
43 | neurotransmitter secretion (GO:0007269) | 3.91364024 |
44 | synaptic vesicle endocytosis (GO:0048488) | 3.91196507 |
45 | neuron recognition (GO:0008038) | 3.89030643 |
46 | response to histamine (GO:0034776) | 3.81964704 |
47 | positive regulation of synapse maturation (GO:0090129) | 3.73645282 |
48 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.73209450 |
49 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.73209450 |
50 | postsynaptic membrane organization (GO:0001941) | 3.73202472 |
51 | regulation of synaptic plasticity (GO:0048167) | 3.71515098 |
52 | positive regulation of membrane potential (GO:0045838) | 3.70843387 |
53 | positive regulation of vesicle fusion (GO:0031340) | 3.70133134 |
54 | dicarboxylic acid catabolic process (GO:0043649) | 3.69529383 |
55 | positive regulation of neurotransmitter transport (GO:0051590) | 3.62299802 |
56 | long-term memory (GO:0007616) | 3.60645850 |
57 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.53196033 |
58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.52161178 |
59 | proline transport (GO:0015824) | 3.51527324 |
60 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.50629972 |
61 | behavioral defense response (GO:0002209) | 3.50022857 |
62 | behavioral fear response (GO:0001662) | 3.50022857 |
63 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.48878514 |
64 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.48878514 |
65 | startle response (GO:0001964) | 3.44853207 |
66 | axonal fasciculation (GO:0007413) | 3.42332502 |
67 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.41779371 |
68 | regulation of glutamate secretion (GO:0014048) | 3.39877895 |
69 | regulation of protein kinase A signaling (GO:0010738) | 3.39548214 |
70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39508123 |
71 | transferrin transport (GO:0033572) | 3.39351651 |
72 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.34622224 |
73 | regulation of neurotransmitter secretion (GO:0046928) | 3.34570406 |
74 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.33595247 |
75 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.32514923 |
76 | succinate metabolic process (GO:0006105) | 3.31950410 |
77 | fear response (GO:0042596) | 3.31919324 |
78 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.30225971 |
79 | behavioral response to cocaine (GO:0048148) | 3.30203719 |
80 | neurotransmitter transport (GO:0006836) | 3.30102256 |
81 | regulation of synapse structural plasticity (GO:0051823) | 3.29355139 |
82 | long term synaptic depression (GO:0060292) | 3.25106787 |
83 | neurotransmitter biosynthetic process (GO:0042136) | 3.24812817 |
84 | amino acid import (GO:0043090) | 3.24268599 |
85 | C4-dicarboxylate transport (GO:0015740) | 3.23123158 |
86 | regulation of vesicle fusion (GO:0031338) | 3.21619823 |
87 | detection of calcium ion (GO:0005513) | 3.18295124 |
88 | innervation (GO:0060384) | 3.18146357 |
89 | membrane depolarization (GO:0051899) | 3.18011860 |
90 | positive regulation of synaptic transmission (GO:0050806) | 3.17609757 |
91 | trivalent inorganic cation transport (GO:0072512) | 3.17064063 |
92 | ferric iron transport (GO:0015682) | 3.17064063 |
93 | transmission of nerve impulse (GO:0019226) | 3.15522362 |
94 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.14231531 |
95 | dendrite morphogenesis (GO:0048813) | 3.12764382 |
96 | negative regulation of neurotransmitter transport (GO:0051589) | 3.12572020 |
97 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.12420139 |
98 | dendritic spine morphogenesis (GO:0060997) | 3.10968239 |
99 | regulation of female receptivity (GO:0045924) | 3.10685420 |
100 | behavioral response to ethanol (GO:0048149) | 3.10526745 |
101 | learning (GO:0007612) | 3.10072426 |
102 | serotonin metabolic process (GO:0042428) | 3.09988272 |
103 | regulation of neurotransmitter transport (GO:0051588) | 3.08879179 |
104 | synaptic transmission, dopaminergic (GO:0001963) | 3.06319650 |
105 | regulation of neurotransmitter levels (GO:0001505) | 3.05440910 |
106 | female mating behavior (GO:0060180) | 3.04909401 |
107 | cochlea development (GO:0090102) | 3.04531591 |
108 | regulation of synaptic transmission (GO:0050804) | 3.03257824 |
109 | regulation of synapse maturation (GO:0090128) | 3.02467198 |
110 | synaptic transmission (GO:0007268) | 3.02417220 |
111 | cellular response to ammonium ion (GO:0071242) | 3.02175960 |
112 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01054806 |
113 | regulation of dendritic spine development (GO:0060998) | 3.00714653 |
114 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.00377664 |
115 | synaptic vesicle transport (GO:0048489) | 3.00362758 |
116 | establishment of synaptic vesicle localization (GO:0097480) | 3.00362758 |
117 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.99932420 |
118 | organelle transport along microtubule (GO:0072384) | 2.98582267 |
119 | glycine transport (GO:0015816) | 2.97664334 |
120 | negative regulation of dendrite development (GO:2000171) | 2.96640198 |
121 | gamma-aminobutyric acid transport (GO:0015812) | 2.92952597 |
122 | positive regulation of synapse assembly (GO:0051965) | 2.91786151 |
123 | synapse organization (GO:0050808) | 2.87967536 |
124 | righting reflex (GO:0060013) | 2.86036814 |
125 | calcium ion-dependent exocytosis (GO:0017156) | 2.85646866 |
126 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.84857061 |
127 | chemosensory behavior (GO:0007635) | 2.84028352 |
128 | layer formation in cerebral cortex (GO:0021819) | 2.83825783 |
129 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.83230345 |
130 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.81420736 |
131 | regulation of cell communication by electrical coupling (GO:0010649) | 2.81307038 |
132 | acidic amino acid transport (GO:0015800) | 2.81264312 |
133 | establishment of vesicle localization (GO:0051650) | 2.79711707 |
134 | regulation of mitochondrial fission (GO:0090140) | 2.77352239 |
135 | response to dietary excess (GO:0002021) | 2.76912083 |
136 | signal release (GO:0023061) | 2.70742225 |
137 | regulation of synapse assembly (GO:0051963) | 2.70512519 |
138 | positive regulation of amino acid transport (GO:0051957) | 2.70148694 |
139 | social behavior (GO:0035176) | 2.67769443 |
140 | intraspecies interaction between organisms (GO:0051703) | 2.67769443 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.19120850 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.57908674 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10281908 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93509964 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90307318 |
6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.67611496 |
7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56767561 |
8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53670937 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.48514272 |
10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.48514272 |
11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.44092139 |
12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42880556 |
13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37551075 |
14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.34703847 |
15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32352467 |
16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.30828172 |
17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29430663 |
18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.27629857 |
19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.18035238 |
20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.14981015 |
21 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.10406271 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05193131 |
23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.03142516 |
24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.02176562 |
25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.99759088 |
26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.99675330 |
27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.96269219 |
28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94341789 |
29 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.93458447 |
30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.92054313 |
31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.90341087 |
32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.89780353 |
33 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.88298669 |
34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82078428 |
35 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.79328506 |
36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.73846593 |
37 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.70428099 |
38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69454868 |
39 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.59134182 |
40 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56264647 |
41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.56136916 |
42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.54290148 |
43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53759134 |
44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53369778 |
45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51761071 |
46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.50416418 |
47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50048233 |
48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.49053136 |
49 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.48564357 |
50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48349382 |
51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46297602 |
52 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.42725397 |
53 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40532290 |
54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38080857 |
55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37601062 |
56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37393526 |
57 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32535349 |
58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31615985 |
59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31209384 |
60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.31153642 |
61 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30820192 |
62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28756038 |
63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28545706 |
64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28313210 |
65 | EWS_26573619_Chip-Seq_HEK293_Human | 1.27711361 |
66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25425445 |
67 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24991439 |
68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20552835 |
69 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20451422 |
70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18735562 |
71 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18721391 |
72 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18123654 |
73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17899865 |
74 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16001929 |
75 | JUN_21703547_ChIP-Seq_K562_Human | 1.15953428 |
76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15605888 |
77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15458222 |
78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15070271 |
79 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13646357 |
80 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11887421 |
81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11816675 |
82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11644720 |
83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10682820 |
84 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10463875 |
85 | AR_19668381_ChIP-Seq_PC3_Human | 1.10289016 |
86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10153568 |
87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08869985 |
88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07917817 |
89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07249297 |
90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05153070 |
91 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05033694 |
92 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.04262448 |
93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03912123 |
94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03804281 |
95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01950441 |
96 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.01823232 |
97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00705956 |
98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00573526 |
99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00541705 |
100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99637767 |
101 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99637767 |
102 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99279730 |
103 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99055824 |
104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98177278 |
105 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97776736 |
106 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97734279 |
107 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97706813 |
108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96602089 |
109 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96093504 |
110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95771028 |
111 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94723788 |
112 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94723788 |
113 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94627637 |
114 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93207313 |
115 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.91973655 |
116 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.91969561 |
117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91625124 |
118 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.91362380 |
119 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.90740603 |
120 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.89234592 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.21404475 |
2 | MP0003880_abnormal_central_pattern | 5.69014621 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.18918180 |
4 | MP0009745_abnormal_behavioral_response | 3.55773226 |
5 | MP0002063_abnormal_learning/memory/cond | 3.47415273 |
6 | MP0001968_abnormal_touch/_nociception | 3.45775301 |
7 | MP0004270_analgesia | 3.43794063 |
8 | MP0002064_seizures | 3.31811785 |
9 | MP0002736_abnormal_nociception_after | 3.30606481 |
10 | MP0002572_abnormal_emotion/affect_behav | 3.05391435 |
11 | MP0009046_muscle_twitch | 2.92697081 |
12 | MP0001501_abnormal_sleep_pattern | 2.67649357 |
13 | MP0002272_abnormal_nervous_system | 2.65577990 |
14 | MP0001440_abnormal_grooming_behavior | 2.48050659 |
15 | MP0002735_abnormal_chemical_nociception | 2.48038225 |
16 | MP0002734_abnormal_mechanical_nocicepti | 2.43958403 |
17 | MP0001486_abnormal_startle_reflex | 2.37756347 |
18 | MP0009780_abnormal_chondrocyte_physiolo | 2.03432698 |
19 | MP0002067_abnormal_sensory_capabilities | 2.01671765 |
20 | MP0001986_abnormal_taste_sensitivity | 1.97376668 |
21 | MP0002837_dystrophic_cardiac_calcinosis | 1.97099938 |
22 | MP0001529_abnormal_vocalization | 1.87507443 |
23 | MP0001970_abnormal_pain_threshold | 1.81542103 |
24 | MP0006276_abnormal_autonomic_nervous | 1.80306415 |
25 | MP0003879_abnormal_hair_cell | 1.77921267 |
26 | MP0003787_abnormal_imprinting | 1.76507731 |
27 | MP0002733_abnormal_thermal_nociception | 1.74581736 |
28 | MP0002822_catalepsy | 1.74334162 |
29 | MP0005386_behavior/neurological_phenoty | 1.70814504 |
30 | MP0004924_abnormal_behavior | 1.70814504 |
31 | MP0005423_abnormal_somatic_nervous | 1.67057622 |
32 | MP0000778_abnormal_nervous_system | 1.66546890 |
33 | MP0005646_abnormal_pituitary_gland | 1.63927027 |
34 | MP0002557_abnormal_social/conspecific_i | 1.63506198 |
35 | MP0002184_abnormal_innervation | 1.61626858 |
36 | MP0001984_abnormal_olfaction | 1.59968663 |
37 | MP0004858_abnormal_nervous_system | 1.59624421 |
38 | MP0003329_amyloid_beta_deposits | 1.57485584 |
39 | MP0004811_abnormal_neuron_physiology | 1.55644392 |
40 | MP0002102_abnormal_ear_morphology | 1.53913514 |
41 | MP0001270_distended_abdomen | 1.51462610 |
42 | MP0001905_abnormal_dopamine_level | 1.51450872 |
43 | MP0001188_hyperpigmentation | 1.51288527 |
44 | MP0005645_abnormal_hypothalamus_physiol | 1.45356032 |
45 | MP0008569_lethality_at_weaning | 1.44728980 |
46 | MP0003121_genomic_imprinting | 1.44255859 |
47 | MP0002876_abnormal_thyroid_physiology | 1.38235049 |
48 | MP0003122_maternal_imprinting | 1.34370350 |
49 | MP0002066_abnormal_motor_capabilities/c | 1.31841311 |
50 | MP0002909_abnormal_adrenal_gland | 1.27442709 |
51 | MP0003633_abnormal_nervous_system | 1.25525452 |
52 | MP0004484_altered_response_of | 1.23737886 |
53 | MP0000955_abnormal_spinal_cord | 1.23567881 |
54 | MP0002882_abnormal_neuron_morphology | 1.20797213 |
55 | MP0003646_muscle_fatigue | 1.16435753 |
56 | MP0008872_abnormal_physiological_respon | 1.12880099 |
57 | MP0000751_myopathy | 1.11614391 |
58 | MP0000049_abnormal_middle_ear | 1.10031030 |
59 | MP0004142_abnormal_muscle_tone | 1.09171170 |
60 | MP0001502_abnormal_circadian_rhythm | 1.08919466 |
61 | MP0008789_abnormal_olfactory_epithelium | 1.08867066 |
62 | MP0004147_increased_porphyrin_level | 1.06933738 |
63 | MP0003631_nervous_system_phenotype | 1.05188908 |
64 | MP0003385_abnormal_body_wall | 1.05057741 |
65 | MP0008874_decreased_physiological_sensi | 1.03230556 |
66 | MP0004043_abnormal_pH_regulation | 0.98328001 |
67 | MP0002234_abnormal_pharynx_morphology | 0.98175685 |
68 | MP0002332_abnormal_exercise_endurance | 0.97678251 |
69 | MP0005535_abnormal_body_temperature | 0.96519684 |
70 | MP0001664_abnormal_digestion | 0.96502198 |
71 | MP0002751_abnormal_autonomic_nervous | 0.95017501 |
72 | MP0002152_abnormal_brain_morphology | 0.94359830 |
73 | MP0010386_abnormal_urinary_bladder | 0.93560506 |
74 | MP0000013_abnormal_adipose_tissue | 0.93530974 |
75 | MP0002069_abnormal_eating/drinking_beha | 0.93530890 |
76 | MP0000569_abnormal_digit_pigmentation | 0.91935848 |
77 | MP0002638_abnormal_pupillary_reflex | 0.89041231 |
78 | MP0001299_abnormal_eye_distance/ | 0.88289693 |
79 | MP0001963_abnormal_hearing_physiology | 0.87231264 |
80 | MP0005253_abnormal_eye_physiology | 0.87101434 |
81 | MP0000920_abnormal_myelination | 0.86732250 |
82 | MP0004215_abnormal_myocardial_fiber | 0.86639040 |
83 | MP0004233_abnormal_muscle_weight | 0.86332585 |
84 | MP0005410_abnormal_fertilization | 0.86143697 |
85 | MP0005551_abnormal_eye_electrophysiolog | 0.86082803 |
86 | MP0004885_abnormal_endolymph | 0.85553367 |
87 | MP0004085_abnormal_heartbeat | 0.85444488 |
88 | MP0000516_abnormal_urinary_system | 0.84361802 |
89 | MP0005367_renal/urinary_system_phenotyp | 0.84361802 |
90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82108426 |
91 | MP0005171_absent_coat_pigmentation | 0.80940608 |
92 | MP0004145_abnormal_muscle_electrophysio | 0.80665972 |
93 | MP0003938_abnormal_ear_development | 0.78403049 |
94 | MP0004742_abnormal_vestibular_system | 0.76283686 |
95 | MP0002229_neurodegeneration | 0.74956294 |
96 | MP0002653_abnormal_ependyma_morphology | 0.73550372 |
97 | MP0003137_abnormal_impulse_conducting | 0.73456221 |
98 | MP0005394_taste/olfaction_phenotype | 0.69732779 |
99 | MP0005499_abnormal_olfactory_system | 0.69732779 |
100 | MP0008004_abnormal_stomach_pH | 0.69472236 |
101 | MP0003861_abnormal_nervous_system | 0.68857587 |
102 | MP0001765_abnormal_ion_homeostasis | 0.67914466 |
103 | MP0004510_myositis | 0.67556471 |
104 | MP0001177_atelectasis | 0.67307669 |
105 | MP0003690_abnormal_glial_cell | 0.65027071 |
106 | MP0008995_early_reproductive_senescence | 0.64953714 |
107 | MP0000604_amyloidosis | 0.64615871 |
108 | MP0003183_abnormal_peptide_metabolism | 0.64151310 |
109 | MP0003075_altered_response_to | 0.63503963 |
110 | MP0000750_abnormal_muscle_regeneration | 0.63040553 |
111 | MP0008877_abnormal_DNA_methylation | 0.62917793 |
112 | MP0000631_abnormal_neuroendocrine_gland | 0.62530727 |
113 | MP0005409_darkened_coat_color | 0.61119248 |
114 | MP0002752_abnormal_somatic_nervous | 0.60605935 |
115 | MP0005167_abnormal_blood-brain_barrier | 0.57465067 |
116 | MP0003632_abnormal_nervous_system | 0.56833679 |
117 | MP0000026_abnormal_inner_ear | 0.54137739 |
118 | MP0005623_abnormal_meninges_morphology | 0.52135061 |
119 | MP0004036_abnormal_muscle_relaxation | 0.52101533 |
120 | MP0001943_abnormal_respiration | 0.51025223 |
121 | MP0005620_abnormal_muscle_contractility | 0.50913372 |
122 | MP0005187_abnormal_penis_morphology | 0.50572949 |
123 | MP0003634_abnormal_glial_cell | 0.50464480 |
124 | MP0005595_abnormal_vascular_smooth | 0.49342851 |
125 | MP0001485_abnormal_pinna_reflex | 0.46183816 |
126 | MP0006292_abnormal_olfactory_placode | 0.46136054 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.72975635 |
2 | Focal seizures (HP:0007359) | 5.94882997 |
3 | Epileptic encephalopathy (HP:0200134) | 5.81254427 |
4 | Myokymia (HP:0002411) | 5.51994218 |
5 | Hyperventilation (HP:0002883) | 5.41572830 |
6 | Visual hallucinations (HP:0002367) | 5.31262043 |
7 | Atonic seizures (HP:0010819) | 5.23609021 |
8 | Febrile seizures (HP:0002373) | 4.70889607 |
9 | Absence seizures (HP:0002121) | 4.56902476 |
10 | Dialeptic seizures (HP:0011146) | 4.32153518 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 4.10448493 |
12 | Progressive cerebellar ataxia (HP:0002073) | 3.98741406 |
13 | Broad-based gait (HP:0002136) | 3.80143007 |
14 | Limb dystonia (HP:0002451) | 3.64507898 |
15 | Amblyopia (HP:0000646) | 3.53878745 |
16 | Amyotrophic lateral sclerosis (HP:0007354) | 3.53543195 |
17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.48875349 |
18 | Spastic tetraplegia (HP:0002510) | 3.37651888 |
19 | Spastic diplegia (HP:0001264) | 3.24344970 |
20 | Gaze-evoked nystagmus (HP:0000640) | 3.21306506 |
21 | Lissencephaly (HP:0001339) | 3.18511156 |
22 | Epileptiform EEG discharges (HP:0011182) | 3.06248954 |
23 | Poor eye contact (HP:0000817) | 3.05568114 |
24 | Drooling (HP:0002307) | 3.02211797 |
25 | Excessive salivation (HP:0003781) | 3.02211797 |
26 | Cerebral inclusion bodies (HP:0100314) | 2.99970543 |
27 | Truncal ataxia (HP:0002078) | 2.98188120 |
28 | Absent speech (HP:0001344) | 2.96804911 |
29 | Hepatoblastoma (HP:0002884) | 2.91504169 |
30 | Abnormal eating behavior (HP:0100738) | 2.88546119 |
31 | Anxiety (HP:0000739) | 2.87359622 |
32 | Absent/shortened dynein arms (HP:0200106) | 2.86959508 |
33 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.86959508 |
34 | Upper limb muscle weakness (HP:0003484) | 2.83891053 |
35 | Split foot (HP:0001839) | 2.83355095 |
36 | Dysmetria (HP:0001310) | 2.79433867 |
37 | Dysdiadochokinesis (HP:0002075) | 2.73854940 |
38 | Abnormality of the labia minora (HP:0012880) | 2.73002433 |
39 | Peripheral hypomyelination (HP:0007182) | 2.70442347 |
40 | Depression (HP:0000716) | 2.70235458 |
41 | Polyphagia (HP:0002591) | 2.68489766 |
42 | Lower limb muscle weakness (HP:0007340) | 2.66219792 |
43 | Unilateral renal agenesis (HP:0000122) | 2.65465141 |
44 | Abnormal social behavior (HP:0012433) | 2.64789644 |
45 | Impaired social interactions (HP:0000735) | 2.64789644 |
46 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.62363182 |
47 | Diplopia (HP:0000651) | 2.61470870 |
48 | Abnormality of binocular vision (HP:0011514) | 2.61470870 |
49 | EEG with generalized epileptiform discharges (HP:0011198) | 2.61051643 |
50 | Protruding tongue (HP:0010808) | 2.58724671 |
51 | Impaired smooth pursuit (HP:0007772) | 2.55088193 |
52 | Poor suck (HP:0002033) | 2.51830451 |
53 | Supranuclear gaze palsy (HP:0000605) | 2.51213016 |
54 | Action tremor (HP:0002345) | 2.50743850 |
55 | Thyroid-stimulating hormone excess (HP:0002925) | 2.50081151 |
56 | Pachygyria (HP:0001302) | 2.49463971 |
57 | Inability to walk (HP:0002540) | 2.49277382 |
58 | Delusions (HP:0000746) | 2.47537793 |
59 | Gait imbalance (HP:0002141) | 2.45798733 |
60 | Impaired vibratory sensation (HP:0002495) | 2.45740787 |
61 | Termporal pattern (HP:0011008) | 2.45120708 |
62 | Insidious onset (HP:0003587) | 2.45120708 |
63 | Clonus (HP:0002169) | 2.41243843 |
64 | Type II lissencephaly (HP:0007260) | 2.41173987 |
65 | Dysmetric saccades (HP:0000641) | 2.40654722 |
66 | Genital tract atresia (HP:0001827) | 2.40616194 |
67 | Hypsarrhythmia (HP:0002521) | 2.39026528 |
68 | Cerebral hypomyelination (HP:0006808) | 2.38871021 |
69 | Postural instability (HP:0002172) | 2.38734416 |
70 | Abnormal hair whorl (HP:0010721) | 2.38102428 |
71 | Vaginal atresia (HP:0000148) | 2.37381643 |
72 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.37070652 |
73 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.37070652 |
74 | Pheochromocytoma (HP:0002666) | 2.34500436 |
75 | Medial flaring of the eyebrow (HP:0010747) | 2.33745424 |
76 | Bradykinesia (HP:0002067) | 2.29738110 |
77 | Fetal akinesia sequence (HP:0001989) | 2.29711133 |
78 | Generalized myoclonic seizures (HP:0002123) | 2.28171091 |
79 | Congenital primary aphakia (HP:0007707) | 2.22727606 |
80 | Status epilepticus (HP:0002133) | 2.22148338 |
81 | Blue irides (HP:0000635) | 2.21976700 |
82 | Hemiparesis (HP:0001269) | 2.17690719 |
83 | Nephrogenic diabetes insipidus (HP:0009806) | 2.16752628 |
84 | Fair hair (HP:0002286) | 2.14720521 |
85 | Progressive inability to walk (HP:0002505) | 2.14556182 |
86 | Hypoplasia of the corpus callosum (HP:0002079) | 2.14337271 |
87 | Neuroendocrine neoplasm (HP:0100634) | 2.14060855 |
88 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.13739939 |
89 | Abnormality of the lower motor neuron (HP:0002366) | 2.12215271 |
90 | Scanning speech (HP:0002168) | 2.12163159 |
91 | Urinary urgency (HP:0000012) | 2.12032217 |
92 | Esotropia (HP:0000565) | 2.11994265 |
93 | Neurofibrillary tangles (HP:0002185) | 2.10759309 |
94 | Resting tremor (HP:0002322) | 2.10035849 |
95 | Acute necrotizing encephalopathy (HP:0006965) | 2.06915698 |
96 | Decreased lacrimation (HP:0000633) | 2.05059223 |
97 | Shoulder girdle muscle weakness (HP:0003547) | 2.04989844 |
98 | Focal dystonia (HP:0004373) | 2.04840890 |
99 | Broad alveolar ridges (HP:0000187) | 2.04780098 |
100 | Stereotypic behavior (HP:0000733) | 2.04717298 |
101 | Cortical dysplasia (HP:0002539) | 2.04271479 |
102 | Incomplete penetrance (HP:0003829) | 2.03943404 |
103 | Genetic anticipation (HP:0003743) | 2.03596360 |
104 | Abnormality of the corticospinal tract (HP:0002492) | 2.03576583 |
105 | Abnormality of salivation (HP:0100755) | 2.03171307 |
106 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01612743 |
107 | Generalized hypopigmentation of hair (HP:0011358) | 2.00564058 |
108 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.00539116 |
109 | Hypoplasia of the brainstem (HP:0002365) | 2.00539116 |
110 | Poor coordination (HP:0002370) | 2.00395936 |
111 | Decreased testicular size (HP:0008734) | 1.99854935 |
112 | Intention tremor (HP:0002080) | 1.99015528 |
113 | Optic nerve hypoplasia (HP:0000609) | 1.98878792 |
114 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.98129508 |
115 | Intellectual disability, severe (HP:0010864) | 1.96453917 |
116 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.96004801 |
117 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.96004801 |
118 | Retinal dysplasia (HP:0007973) | 1.95326138 |
119 | Ankle clonus (HP:0011448) | 1.95296935 |
120 | Progressive macrocephaly (HP:0004481) | 1.95279098 |
121 | Psychosis (HP:0000709) | 1.94966485 |
122 | Abnormal ciliary motility (HP:0012262) | 1.94781656 |
123 | Ulnar claw (HP:0001178) | 1.94387541 |
124 | Hyperthyroidism (HP:0000836) | 1.94181365 |
125 | Gait ataxia (HP:0002066) | 1.91084728 |
126 | Muscular hypotonia of the trunk (HP:0008936) | 1.90302710 |
127 | Spastic gait (HP:0002064) | 1.90263843 |
128 | Oligomenorrhea (HP:0000876) | 1.90134034 |
129 | Paraplegia (HP:0010550) | 1.89690042 |
130 | Torticollis (HP:0000473) | 1.88886012 |
131 | Dyskinesia (HP:0100660) | 1.87310264 |
132 | Failure to thrive in infancy (HP:0001531) | 1.87190760 |
133 | Specific learning disability (HP:0001328) | 1.86856325 |
134 | Narrow nasal bridge (HP:0000446) | 1.84823261 |
135 | Cholecystitis (HP:0001082) | 1.84243542 |
136 | Abnormal gallbladder physiology (HP:0012438) | 1.84243542 |
137 | Thickened helices (HP:0000391) | 1.84218849 |
138 | Mutism (HP:0002300) | 1.83394796 |
139 | Alacrima (HP:0000522) | 1.82308912 |
140 | Hypoventilation (HP:0002791) | 1.80934818 |
141 | Intellectual disability, progressive (HP:0006887) | 1.80094247 |
142 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.79967236 |
143 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.79967236 |
144 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.79519715 |
145 | CNS hypomyelination (HP:0003429) | 1.78142184 |
146 | Increased circulating renin level (HP:0000848) | 1.76296643 |
147 | Spastic paraplegia (HP:0001258) | 1.75232359 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.59571001 |
2 | NTRK3 | 4.00495719 |
3 | CASK | 3.82727618 |
4 | MAP3K4 | 3.56679578 |
5 | MAP3K12 | 3.45726452 |
6 | MAP2K7 | 3.39504254 |
7 | RIPK4 | 3.20667668 |
8 | TRIM28 | 2.93642489 |
9 | CDK19 | 2.64201736 |
10 | PLK2 | 2.59321991 |
11 | MAP3K9 | 2.59030495 |
12 | DAPK2 | 2.40228454 |
13 | EPHA3 | 2.28510908 |
14 | MAP2K4 | 2.28121590 |
15 | DAPK1 | 2.24431549 |
16 | MINK1 | 2.21963689 |
17 | STK38L | 1.95619619 |
18 | MAP4K2 | 1.81311753 |
19 | PTK2B | 1.77749548 |
20 | OXSR1 | 1.74919387 |
21 | GRK5 | 1.73946412 |
22 | PRPF4B | 1.71876285 |
23 | BMPR2 | 1.64977900 |
24 | PNCK | 1.63502512 |
25 | CSNK1A1L | 1.62771360 |
26 | MARK1 | 1.61062644 |
27 | CSNK1G3 | 1.55223332 |
28 | FRK | 1.53012878 |
29 | DYRK2 | 1.43523588 |
30 | PAK6 | 1.40389433 |
31 | KSR1 | 1.39777809 |
32 | ARAF | 1.37094447 |
33 | AKT3 | 1.32940056 |
34 | NME1 | 1.30923007 |
35 | NTRK2 | 1.30055408 |
36 | CDK5 | 1.28359774 |
37 | ERBB3 | 1.26914089 |
38 | PRKCG | 1.26756625 |
39 | CAMK2A | 1.24727754 |
40 | KSR2 | 1.22162220 |
41 | CSNK1G1 | 1.17849117 |
42 | RPS6KA4 | 1.17368965 |
43 | FGR | 1.11389625 |
44 | TNIK | 1.10422478 |
45 | FES | 1.09384554 |
46 | PDK4 | 1.09269254 |
47 | PDK3 | 1.09269254 |
48 | MAP3K13 | 1.07540089 |
49 | MAPK13 | 1.04033995 |
50 | CAMK2B | 1.02523731 |
51 | SIK3 | 1.02217801 |
52 | CAMKK1 | 1.01636501 |
53 | PRKD3 | 1.00628304 |
54 | SIK2 | 1.00546935 |
55 | NTRK1 | 0.98794552 |
56 | CCNB1 | 0.95489738 |
57 | PHKG2 | 0.91303912 |
58 | PHKG1 | 0.91303912 |
59 | GRK7 | 0.88230979 |
60 | CAMK1 | 0.84172595 |
61 | STK38 | 0.84092510 |
62 | CAMKK2 | 0.82271221 |
63 | SGK223 | 0.78872588 |
64 | SGK494 | 0.78872588 |
65 | GRK6 | 0.78691975 |
66 | WNK3 | 0.77552819 |
67 | SGK2 | 0.76674849 |
68 | CDK18 | 0.75539345 |
69 | RAF1 | 0.73716133 |
70 | FGFR2 | 0.72764270 |
71 | LIMK1 | 0.72620899 |
72 | TESK1 | 0.72317039 |
73 | FER | 0.71666834 |
74 | BRD4 | 0.71224475 |
75 | CDK14 | 0.69631755 |
76 | CDK15 | 0.69520914 |
77 | DYRK1A | 0.68157764 |
78 | SGK1 | 0.66460071 |
79 | SRPK1 | 0.64748057 |
80 | PKN1 | 0.64416292 |
81 | BRAF | 0.64298341 |
82 | PRKCE | 0.63989067 |
83 | PDK1 | 0.62394198 |
84 | TAOK1 | 0.61972079 |
85 | TSSK6 | 0.61267257 |
86 | MAP3K6 | 0.60169470 |
87 | INSRR | 0.59644059 |
88 | CDK11A | 0.58895966 |
89 | MYLK | 0.58638881 |
90 | STK11 | 0.57785742 |
91 | PDK2 | 0.56741016 |
92 | ADRBK1 | 0.55408456 |
93 | CAMK2D | 0.53621584 |
94 | PDPK1 | 0.53391400 |
95 | UHMK1 | 0.52842290 |
96 | MAP3K2 | 0.52141854 |
97 | DAPK3 | 0.51835463 |
98 | LATS2 | 0.49331916 |
99 | CSNK1D | 0.49181372 |
100 | BCR | 0.48711983 |
101 | ADRBK2 | 0.48030137 |
102 | PAK3 | 0.47915175 |
103 | DYRK1B | 0.45695538 |
104 | PIM2 | 0.45648324 |
105 | CAMK4 | 0.43220313 |
106 | SGK3 | 0.43196593 |
107 | CSNK1A1 | 0.42941963 |
108 | MAP3K5 | 0.41740431 |
109 | MAP2K1 | 0.41189042 |
110 | TYRO3 | 0.41176884 |
111 | PRKCH | 0.38988429 |
112 | CAMK2G | 0.38769645 |
113 | ROCK2 | 0.38520322 |
114 | PRKACB | 0.38195858 |
115 | RET | 0.37169049 |
116 | TNK2 | 0.37168318 |
117 | LMTK2 | 0.36876179 |
118 | MAPK10 | 0.36842592 |
119 | PRKAA1 | 0.34395074 |
120 | MARK2 | 0.34305636 |
121 | MAP3K1 | 0.33972048 |
122 | PRKCZ | 0.33384711 |
123 | MAPK9 | 0.32741783 |
124 | WNK4 | 0.32384506 |
125 | PRKD1 | 0.32347382 |
126 | CSNK1G2 | 0.31308999 |
127 | PRKG1 | 0.31292480 |
128 | PLK3 | 0.30807516 |
129 | PINK1 | 0.30361444 |
130 | IRAK2 | 0.29942725 |
131 | RPS6KA3 | 0.29860491 |
132 | FYN | 0.29732415 |
133 | MAP3K7 | 0.29613219 |
134 | PRKACA | 0.29440438 |
135 | PRKD2 | 0.28477703 |
136 | DYRK3 | 0.27796753 |
137 | PRKACG | 0.26406953 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.31063897 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.62845088 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.95231246 |
4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.94211171 |
5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.89925095 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.76482884 |
7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.73598337 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.54498658 |
9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.48609640 |
10 | * Morphine addiction_Homo sapiens_hsa05032 | 2.41499582 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.35937389 |
12 | * Olfactory transduction_Homo sapiens_hsa04740 | 2.21849442 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12362048 |
14 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.04722996 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00073522 |
16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.99527576 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 1.91417534 |
18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87304686 |
19 | * Taste transduction_Homo sapiens_hsa04742 | 1.80665968 |
20 | * Renin secretion_Homo sapiens_hsa04924 | 1.79065392 |
21 | Long-term depression_Homo sapiens_hsa04730 | 1.78404846 |
22 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.77399248 |
23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77239530 |
24 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.73492138 |
25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71132409 |
26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.62475161 |
27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59317260 |
28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.47893589 |
29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39532403 |
30 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.37225610 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33265303 |
32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32703185 |
33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29605476 |
34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26594186 |
35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26280263 |
36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21906117 |
37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.21436626 |
38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20740382 |
39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20623452 |
40 | Gap junction_Homo sapiens_hsa04540 | 1.20064989 |
41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14730334 |
42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13176067 |
43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09215785 |
44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03623932 |
45 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.98544763 |
46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96610813 |
47 | Axon guidance_Homo sapiens_hsa04360 | 0.95765611 |
48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94964420 |
49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94511939 |
50 | Phototransduction_Homo sapiens_hsa04744 | 0.94280758 |
51 | Glioma_Homo sapiens_hsa05214 | 0.92842512 |
52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92634274 |
53 | Melanogenesis_Homo sapiens_hsa04916 | 0.91704792 |
54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88791580 |
55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84138813 |
56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83097728 |
57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82732461 |
58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.81555577 |
59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77584268 |
60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76755651 |
61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73802982 |
62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72969166 |
63 | Protein export_Homo sapiens_hsa03060 | 0.72270207 |
64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72255278 |
65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70747355 |
66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70606876 |
67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68684791 |
68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68498543 |
69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66448470 |
70 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64146921 |
71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63768044 |
72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59911442 |
73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59017826 |
74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58219324 |
75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57891995 |
76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57845132 |
77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57271214 |
78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54827883 |
79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54491401 |
80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53888475 |
81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53523887 |
82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51798117 |
83 | Phagosome_Homo sapiens_hsa04145 | 0.48927156 |
84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47733506 |
85 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.47730928 |
86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47117545 |
87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46823109 |
88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46471630 |
89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44315651 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44006948 |
91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42386473 |
92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42136501 |
93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36710175 |
94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35954971 |
95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33449423 |
96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32782618 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30911263 |
98 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.29614884 |
99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29314730 |
100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29297833 |
101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28691743 |
102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28679012 |
103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28450296 |
104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28032877 |
105 | Alcoholism_Homo sapiens_hsa05034 | 0.26914386 |
106 | ABC transporters_Homo sapiens_hsa02010 | 0.26732420 |
107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26218375 |
108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26179282 |
109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25689853 |
110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25596734 |
111 | Peroxisome_Homo sapiens_hsa04146 | 0.25329103 |
112 | Prion diseases_Homo sapiens_hsa05020 | 0.24925744 |
113 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.24715731 |
114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23924700 |
115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23477691 |
116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23239755 |
117 | Bile secretion_Homo sapiens_hsa04976 | 0.23090616 |
118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21934270 |
119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.19599027 |
120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19527129 |
121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19337537 |
122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18791568 |
123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17417079 |
124 | Mineral absorption_Homo sapiens_hsa04978 | 0.17407689 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.16685692 |